Brief communication: immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine.
Zheng Quan Toh 
;
Beth Temple;
Tran Ngoc Huu;
Vo Thi Trang Dai;
Nguyen Trong Toan;
Doan Y Uyen;
Kathryn Bright;
Lien Anh Ha Do;
E Kim Mulholland ;
Paul V Licciardi ;
(2020)
Brief communication: immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine.
NPJ VACCINES, 5 (1).
76-.
ISSN 2059-0105
DOI: 10.1038/s41541-020-00225-z
;
Beth Temple;
Tran Ngoc Huu;
Vo Thi Trang Dai;
Nguyen Trong Toan;
Doan Y Uyen;
Kathryn Bright;
Lien Anh Ha Do;
E Kim Mulholland ;
Paul V Licciardi ;
(2020)
Brief communication: immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine.
NPJ VACCINES, 5 (1).
76-.
ISSN 2059-0105
DOI: 10.1038/s41541-020-00225-z
This brief communication describes the findings from a randomised controlled trial in Vietnam that co-administration of measles vaccine (MV) with 10-valent pneumococcal conjugate vaccine (PCV10, Synflorix®, GSK) does not affect the immunogenicity of MV. These findings are most relevant for low- and middle-income countries (LMICs) in Asia considering PCV introduction.
-
picture_as_pdf - Brief communication immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine.pdf
-
subject - Published Version
-
- Available under Creative Commons: 3.0
Downloads